Sermorelin dosing must be individualized based on age, weight, baseline hormone levels, treatment goals, and individual response. Working with a qualified healthcare provider ensures safe and effective protocol development.
Standard sermorelin doses typically range from 200 to 500 mcg per injection, administered subcutaneously. Most providers start at the lower end of this range and adjust based on patient response and tolerance.
Timing of administration is critical for optimal results. Sermorelin is most effective when taken before bedtime, as this aligns with the body's natural growth hormone pulse that occurs during deep sleep. Taking sermorelin 30-60 minutes before sleep on an empty stomach maximizes absorption and effectiveness.
Injection technique involves using a small insulin-type syringe to deliver sermorelin into subcutaneous fat, typically in the abdomen or thigh. The process is relatively painless when performed correctly, and most users become comfortable with self-administration within a few days.
Cycling protocols vary by provider philosophy. Some recommend continuous daily use, while others advocate for cycling patterns such as 5 days on with 2 days off. The cycling approach theoretically prevents receptor desensitization, though evidence supporting this practice is limited.
Dose adjustment should occur gradually under medical supervision. If initial dosing doesn't produce expected results after 4-6 weeks, providers may incrementally increase the dose. Conversely, if side effects occur, reduction may be appropriate.
Oral and sublingual sermorelin formulations are now available from some providers. These formats offer convenience advantages but may require higher doses due to reduced bioavailability compared to injections.
Monitoring response includes tracking subjective improvements in sleep, energy, recovery, and body composition, alongside periodic blood work to assess IGF-1 levels (a marker of growth hormone activity). Most providers recommend follow-up labs after 3-6 months of treatment.